{"id":"b710a265-1c30-4842-8410-aa2af698bb4a","kind":"news","code":"b710a265-1c30-4842-8410-aa2af698bb4a","name":"OpenEvidence reaches USD 300 million ARR, 860 thousand clinician users","nameBasis":"translated-title","summary":"On 2026/7/21, LinkedIn reported that US medical AI question-answering platform OpenEvidence had reached USD 300 million ARR, with approximately 860 thousand clinician users.","description":"","country":null,"category":null,"originalName":"OpenEvidence ARR达到3亿美元，临床医生用户达86万","eventDate":"2026-07-21T00:00:00.000Z","website":"https://www.linkedin.com/posts/dr-lucas-mittelmeier_not-enough-people-are-talking-about-this-share-7485233191688151040-bbN5/","sourceUpdatedAt":"2026-10-13T16:49:23.901Z","englishUpdatedAt":"2026-10-15T23:57:45.676Z","reviewedAt":"2026-10-15T23:57:45.676Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"fff03dfba4e47bae05eada043edd9d4b3132e3a5aa0956d2e39b61340fa2bcf3","companyId":"99e33a90-23c3-4b77-8972-b740ff63f711","foundedYear":null,"logoUrl":null,"originalText":"2026年7月21日，据LinkedIn报道，美国医疗AI问答平台OpenEvidence ARR达到3亿美元，临床医生用户数量达到约86万。","sources":[{"url":"https://www.linkedin.com/posts/dr-lucas-mittelmeier_not-enough-people-are-talking-about-this-share-7485233191688151040-bbN5/","publishedOn":"2026-07-21T00:00:00.000Z"}],"related":[{"id":"99e33a90-23c3-4b77-8972-b740ff63f711","kind":"companies","code":"UB-C1898","name":"OpenEvidence","nameBasis":"source-english","summary":"Evidence-based medical AI question-answering engine for physicians.","description":"AI-powered clinical decision support engine providing evidence-based medical answers for healthcare professionals.","country":"United States","category":null,"originalName":"OpenEvidence","eventDate":null,"website":"https://openevidence.com/","sourceUpdatedAt":"2026-10-05T00:00:00.000Z","englishUpdatedAt":"2026-10-20T18:25:26.426Z","reviewedAt":"2026-10-20T18:25:26.426Z","snapshotAt":"2026-10-20T18:05:01.520Z","sourceHash":"d38d96038e18218c0a0ea6968f027562798c7be10a9a416e83eee85c11088178","companyId":null,"foundedYear":2022,"logoUrl":"https://c.ux-cdn.com/1863156737900573-5aba7b40bf5e48ca8be5896e57b70eca/uniquebase%2Flogos%2Fcompany%2Frecuhrs5xRCNHe%2F4ddc5d3f4989ff03ddf63f8865c4ccc815b212e5a34a48aa5925b024d65a2367.png","path":"/companies/openevidence"}],"path":"/news/b710a265-1c30-4842-8410-aa2af698bb4a","structured":{"city":null,"country":null,"location":null,"role":null,"category":null,"company":{"name":"OpenEvidence","path":"/companies/openevidence"}},"canonical":"https://uniquebase.ai/news/b710a265-1c30-4842-8410-aa2af698bb4a"}